Evidence map›Paper›PMID 26936043›Full record

Trial reportBMC research notes2016

Factors influencing willingness to participate in new drug trial studies: a study among parents whose children were recruited into these trials in northern Ghana.

James Akazili, Samuel Chatio, Fabian Sebastian Achana, Abraham Oduro, Edmund W Kanmiki, Frank Baiden

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC research notes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

James AkaziliNavrongo Health Research Centre, P.O Box 114, Navrongo, Ghana. jakazili@gmail.com.
Samuel ChatioNavrongo Health Research Centre, P.O Box 114, Navrongo, Ghana. schatio@yahoo.co.uk.
Fabian Sebastian AchanaNavrongo Health Research Centre, P.O Box 114, Navrongo, Ghana. fsachana@gmail.com.
Abraham OduroNavrongo Health Research Centre, P.O Box 114, Navrongo, Ghana. Abraham.oduro@navrongo-hrc.org.
Edmund W KanmikiNavrongo Health Research Centre, P.O Box 114, Navrongo, Ghana. Eddy100@hotmail.com.
Frank BaidenEnsign College of Public Health, ER, Kpong, Ghana. baidenf@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the last decade, the number of clinical trials conducted in sub-Saharan Africa has increased significantly which has helped to address priority health problems in the region. Navrongo health research centre since it was established in 1989, has conducted several trial studies including rectal artesunate trial in the Kassena-Nankana districts. However, there is little evidence-based for assessing the impact of new drug trials. This study explored factors that motivate parents to allow their children to participate in new drug trials in northern Ghana.

methodThe study used both quantitative and qualitative methods. The participants were randomly selected from among parents whose children were enrolled in a new drug trial conducted in the Kassena-Nankana districts between 2000 and 2003. QSR Nvivo 9 software was used to code the qualitative data into themes before analysis while STATA software Version 11.2© was used to analyze the quantitative data.

resultsThe results showed that majority (95.9%) of the parents were willing to allow their children to be enrolled in future new drug trials. The main factors motivating their willingness to allow their children to be enrolled in these trials were quality of health care services offered to trial participants (92.9%), detail medical examination (90.8%), promptness of care provided (94.4%) and quality of drugs (91.9%). Other factors mentioned included disease prevention (99.5%) and improved living standard (96.1%). Parents reported that the conduct of these trials had reduced the frequency of disease occurrences in the communities because of the quality of health care services provided to the children recruited into these trial studies.

conclusionThough the implementation of clinical trials in the study area is believed to have positive impact on health status of people particularly trial participants, measures should however be taken to address safety and likely side effects of new drugs given to trial participants during these trial studies.

Indexed as

MotivationAdministration, RectalAdolescentAdultAntimalarialsArtemisininsArtesunateChildCommunity Health ServicesFemaleGhanaHumansInformed ConsentMalariaMaleMiddle AgedAntimalarialsArtemisininsArtesunate

Identifiers

PMID26936043
PMCPMC4776433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.